AgeX Therapeutics, Inc. (AGE)

Stock-Based Compensation

$1.05M

Quarterly · Period ending: · USD

AGE logo

AGE Stock-Based Compensation

Latest reported$1.05M
AGE Quarterly Stock-Based Comp ($235.00K → $1.05M)
High-resolution chart · PNG

AGE stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AgeX Therapeutics, Inc. Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
1,051,000
1,077,000
0
999,000
890,000
956,000
1,999,000
1,051,000
23,000
53,000
503,000
40,000
35,000
70,000
114,000
209,000
198,000
239,000
263,000
272,000
286,000
178,000
182,000
232,000
259,000
260,000
420,000
491,000
515,000
481,000
797,000
210,000
231,000
235,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.